Annexon (ANNX) Other Non Operating Income (2019 - 2021)

Annexon's (ANNX) quarterly Other Non Operating Income came in at $82000.0 in Q3 2021, up 257.69% year-on-year from $22924.7 in Q3 2020, and up 3.8% quarter-over-quarter from $79000.0 in Q2 2021.

Annexon (ANNX) Other Non Operating Income (2019 - 2021) Analysis & Trends

Annexon's Other Non Operating Income history runs 3 years deep, the most recent figure standing at $82000.0 for Q3 2021.

  • On a quarterly basis, Other Non Operating Income rose 257.69% year-over-year to $82000.0 in Q3 2021; TTM through Sep 2021 was $665000.0, a 2560.0% increase from a year earlier, with the FY2020 full-year figure at $426000.0, down 45.52% from the prior year.
  • Other Non Operating Income climbed to $82000.0 in Q3 2021 per ANNX's latest filing, from $79000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $376000.0 in Q2 2019 and bottomed at -$52000.0 in Q3 2020.
  • The 3-year median for Other Non Operating Income is $98500.0 (2020), against an average of $129000.0.
  • Across the five-year window, Other Non Operating Income plunged 123.21% in 2020 and jumped 7800.0% in 2021, its largest moves.
  • Year by year, Other Non Operating Income stood at -$39000.0 in 2019, then jumped by 1028.21% to $362000.0 in 2020, then slumped by 77.35% to $82000.0 in 2021.
  • Per Business Quant, the three latest ANNX Other Non Operating Income figures stand at $82000.0 (Q3 2021), $79000.0 (Q2 2021), and $142000.0 (Q1 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Annexon 1.02 Bn 798.41 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2021 82,000.00
Jun 30, 2021 79,000.00
Mar 31, 2021 142,000.00
Dec 31, 2020 362,000.00
Sep 30, 2020 -52,000.00
Jun 30, 2020 1,000.00
Mar 31, 2020 115,000.00
Dec 31, 2019 -39,000.00
Sep 30, 2019 224,000.00
Jun 30, 2019 376,000.00